Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
1.07
Dollar change
+0.02
Percentage change
1.90
%
Index- P/E- EPS (ttm)-8.13 Insider Own16.99% Shs Outstand10.41M Perf Week7.00%
Market Cap11.14M Forward P/E- EPS next Y-1.44 Insider Trans0.00% Shs Float8.64M Perf Month-14.40%
Income-67.35M PEG- EPS next Q1.98 Inst Own13.83% Short Float3.21% Perf Quarter33.75%
Sales3.83M P/S2.91 EPS this Y73.09% Inst Trans4.38% Short Ratio4.45 Perf Half Y-52.23%
Book/sh-8.07 P/B- EPS next Y41.78% ROA-124.06% Short Interest0.28M Perf Year-68.33%
Cash/sh2.45 P/C0.44 EPS next 5Y- ROE- 52W Range0.60 - 4.20 Perf YTD-69.87%
Dividend Est.- P/FCF- EPS past 5Y6.21% ROI- 52W High-74.54% Beta0.68
Dividend TTM- Quick Ratio0.54 Sales past 5Y105.16% Gross Margin-138.94% 52W Low78.36% ATR (14)0.10
Dividend Ex-Date- Current Ratio0.57 EPS Y/Y TTM35.08% Oper. Margin-1557.35% RSI (14)45.40 Volatility5.34% 7.41%
Employees107 Debt/Eq- Sales Y/Y TTM378.62% Profit Margin-1758.92% Recom1.67 Target Price9.67
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q43.26% Payout- Rel Volume0.22 Prev Close1.05
Sales Surprise-18.65% EPS Surprise18.12% Sales Q/Q489.76% EarningsAug 13 BMO Avg Volume62.31K Price1.07
SMA20-2.97% SMA50-10.65% SMA200-30.79% Trades Volume13,522 Change1.90%
Date Action Analyst Rating Change Price Target Change
Mar-30-21Initiated Cantor Fitzgerald Overweight $8
Nov-05-20Initiated Ascendiant Capital Markets Buy $5
Jun-28-18Initiated Maxim Group Buy $5
Today 08:31AM
Oct-30-24 08:31AM
Oct-15-24 07:51AM
Oct-10-24 07:51AM
Oct-09-24 08:01AM
07:49AM Loading…
Oct-08-24 07:49AM
Oct-01-24 08:01AM
Sep-24-24 08:01AM
Sep-16-24 04:30PM
Sep-10-24 07:56AM
Sep-03-24 07:51AM
Aug-20-24 08:16AM
Aug-13-24 08:16AM
08:01AM
Aug-12-24 08:07AM
08:31AM Loading…
Aug-08-24 08:31AM
Aug-06-24 08:15AM
Aug-05-24 08:15AM
Jul-30-24 08:15AM
Jul-29-24 08:15AM
Jul-23-24 08:01AM
Jul-11-24 08:31AM
Jul-02-24 07:55AM
Jun-13-24 07:58AM
Jun-12-24 08:05AM
May-14-24 08:21AM
07:53AM
May-13-24 08:43PM
08:00AM
May-09-24 07:49AM
07:39AM Loading…
May-07-24 07:39AM
May-03-24 08:35AM
May-02-24 08:35AM
07:49AM
Apr-30-24 07:35AM
Apr-29-24 08:47AM
Apr-10-24 06:15PM
Apr-08-24 08:30AM
Mar-28-24 09:47AM
Mar-27-24 12:35PM
05:52AM
Mar-26-24 07:32PM
Mar-25-24 05:30PM
Mar-21-24 09:30AM
08:30AM
Mar-20-24 08:30AM
Mar-13-24 08:30AM
Mar-12-24 08:30AM
Feb-16-24 05:00PM
Feb-15-24 07:45AM
Feb-08-24 07:45AM
Dec-12-23 08:30AM
Dec-11-23 09:00AM
Dec-05-23 08:55AM
Dec-04-23 04:20PM
Dec-01-23 10:00AM
Nov-20-23 12:44PM
Nov-16-23 09:07AM
09:00AM
Nov-14-23 05:43PM
Nov-13-23 05:40PM
Nov-09-23 09:00AM
Nov-02-23 09:18AM
Nov-01-23 09:10AM
Oct-31-23 09:00AM
08:55AM
Sep-21-23 08:30AM
Sep-07-23 09:20AM
Sep-06-23 09:00AM
Aug-30-23 09:55AM
Aug-24-23 09:00AM
Aug-22-23 05:30PM
Aug-17-23 03:39AM
Aug-15-23 08:17PM
Aug-14-23 06:48PM
Jul-31-23 06:19PM
06:00PM
Jul-26-23 08:30AM
Jul-19-23 09:04AM
Jun-28-23 04:05PM
Jun-14-23 04:05PM
Jun-05-23 07:00AM
Jun-02-23 07:00AM
May-24-23 08:00AM
May-18-23 12:03PM
12:12AM
May-16-23 05:00PM
May-15-23 06:21PM
May-11-23 08:45AM
May-05-23 09:00AM
09:00AM
Apr-25-23 08:45AM
Apr-19-23 08:45AM
Apr-17-23 09:45PM
Mar-31-23 12:45PM
Mar-20-23 09:03PM
Mar-17-23 12:00PM
04:15AM
Mar-16-23 01:22AM
Mar-14-23 07:09PM
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. The company's products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. PAVmed was founded on June 26, 2014 and is headquartered in New York, NY.